Malachite Innovations, Inc. (“Malachite”) is a public holding company dedicated to improving the health and wellness of people and the planet through a novel and innovative approach to impact investing. Malachite owns and operates a balanced portfolio of operating businesses focused on developing long-term solutions to environmental, social and health challenges, with a particular focus on economically disadvantaged communities. Malachite takes an opportunistic approach to impact investing by leveraging its competitive advantages and looking at solving old problems in new ways. Malachite seeks to thoughtfully allocate its capital into ventures that are expected to make a positive impact on the people-planet ecosystem and generate strong investment returns for our shareholders.
Company profile
Ticker
RNGE, MLCT
Exchange
Website
CEO
Michael Cavanaugh
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Syneos Health • Icon • Medpace • Incyte • Zymergen • OmniAb ...
Former names
Legend Mining Inc., MALACHITE INNOVATIONS, INC., Stevia First Corp., Vitality Biopharma, Inc.
SEC CIK
Corporate docs
Subsidiaries
CLV Azurite Land, LLC • Collins Building & Contracting, Inc. • Graphium Biosciences, Inc. • Range Environmental Resources, Inc. • Range Land, LLC • Range Minerals, LLC • Range Natural Resources, Inc. • Range Reclaim, LLC • Range Security, LLC • Range Security Resources, LLC ...
IRS number
753268988
RNGE stock data
Latest filings (excl ownership)
8-K
Range Impact Reports 4Q 2023 and Full Year 2023 Financial Results
29 Mar 24
10-K
2023 FY
Annual report
29 Mar 24
8-K
Range Impact Announces $1.7 Million Capital Raise Led by Strategic Investors
21 Dec 23
8-K
Entry into a Material Definitive Agreement
14 Dec 23
8-K
Malachite Innovations Reports Third Quarter 2023 Results
14 Nov 23
8-K/A
Other Events
14 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Entry into a Material Definitive Agreement
1 Nov 23
8-K
Malachite Innovations Announces Closing the Acquisition of Its Third Reclamation Business In West Virginia
5 Sep 23
8-K
Entry into a Material Definitive Agreement
30 Aug 23
Latest ownership filings
4
EDWARD F FEIGHAN
12 Jan 24
4
Michael R. Cavanaugh
12 Jan 24
4
Richard F Celeste
12 Jan 24
4
Michael R. Cavanaugh
26 Dec 23
4
EDWARD F FEIGHAN
26 Dec 23
4
Joseph E. LoConti
14 Dec 23
4/A
Change in insider ownership (amended)
7 Nov 23
SC 13G/A
Indemnity National Insurance Co
7 Nov 23
4
Joseph E. LoConti
3 Nov 23
SC 13G/A
Indemnity National Insurance Co
29 Aug 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Mar 21 | Mar 20 | Mar 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.03 mm | 1.03 mm | 1.03 mm | 1.03 mm | 1.03 mm | 1.03 mm |
Cash burn (monthly) | (no burn) | 10.88 k | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 74.56 k | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 951.73 k | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 87.5 | n/a | n/a | n/a | n/a |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Dec 23 | Michael R. Cavanaugh | Common Stock | Buy | Acquire P | No | No | 0.15 | 1,000,000 | 150.00 k | 1,879,791 |
21 Dec 23 | Edward F Feighan | Common Stock | Buy | Acquire P | No | No | 0.15 | 666,667 | 100.00 k | 3,005,689 |
21 Dec 23 | Edward F Feighan | Stock Option Common Stock | Grant | Acquire A | No | No | 0.212 | 250,000 | 53.00 k | 1,833,333 |
21 Dec 23 | Michael R. Cavanaugh | Stock Option Common Stock | Grant | Acquire A | No | No | 0.212 | 1,000,000 | 212.00 k | 2,850,000 |
21 Dec 23 | Richard F Celeste | Stock Option Common Stock | Grant | Dispose A | No | No | 0.212 | 250,000 | 53.00 k | 1,250,000 |